Recursion Pharmaceuticals Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
5.50
0.18
(3.38%)
Volume:
12,766,775
52 week range:
3.79 - 12.36
Market Cap:
2.211B
Company Description:
Recursion Pharmaceuticals, Inc. engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. Its preclinical stage product includes REC-3964 to treat Clostridium difficile colitis; REC-64917 for the treat of neural or systemic inflammation. REC-64151 for the treatment of immune checkpoint resistance in KRAS/STK11 mutant non-small cell lung cancer.